Endo International
ENDPQ
#10594
Rank
S$0.18 M
Marketcap
S$0.0007775
Share price
0.00%
Change (1 day)
-94.19%
Change (1 year)

P/E ratio for Endo International (ENDPQ)

P/E ratio on October 28, 2022 (TTM): -0.0001

According to Endo International 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.000149254. At the end of 2022 the company had a P/E ratio of -0.0056.

P/E ratio history for Endo International from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-0.0056-99.61%
2021-1.43
2019-2.5258.89%
2018-1.5986.75%
2017-0.8498-22.5%
2016-1.10-87.51%
2015-8.78-35.97%
2014-13.720.47%
2013-11.4

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Cara Therapeutics
CARA
-0.2533 169,632.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
-6.56 4,391,929.69%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.